Global Sickle-Cell Anemia Therapeutics Market Analysis 2018 - Forecast to 2025

Global Sickle-Cell Anemia Therapeutics Market Analysis 2018 - Forecast to 2025

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Sickle-Cell Anemia Therapeutics Market by Therapy Type
5.1 Introduction
5.2 Blood Transfusion
5.3 Gene Therapy
5.4 Bone Marrow Transplant
5.5 Medications
5.5.1 Vaccines
5.5.2 Antibiotics
5.5.3 Analgesics
5.5.4 Antimetabolites
5.5.5 Folic Acid
5.5.6 Pain-Relieving Medications
5.5.7 Hydroxyurea
5.5.8 Other Medications
6 Sickle-Cell Anemia Therapeutics Market by End User
6.1 Introduction
6.2 Private Clinics
6.3 Hospitals
6.4 Government
6.5 Infusion Centers
6.6 Home Healthcare
6.7 Other End Users
7 Geographical Segmentation
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 South America
7.4.1 Argentina
7.4.2 Brazil
7.4.3 Venezuela
7.4.4 Chile
7.4.5 Peru
7.5 Middle East & Africa
7.5.1 UAE
7.5.2 Saudi Arabia
7.5.3 Qatar
7.5.4 Iran
7.5.5 South Africa
7.5.6 Rest of MEA
8 Vendor Landscaping
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiles
9.1 Johnson & Johnson
9.2 Baxter
9.3 Daiichi Sankyo
9.4 Eli Lilly
9.5 Pfizer
9.6 Merck Sharp & Dohme
9.7 Novartis
9.8 Bristol-Myers Squibb
9.9 Gilead Sciences
9.10 Sanofi
9.11 Global Blood Therapeutics
9.12 Mast Therapeutics
9.13 Bluebird Bio
9.14 HemaQuest Pharmaceuticals
9.15 GlycoMimetics
9.16 Emmaus Medical
10 Appendix
11 Disclaimer
List of Tables
Table 1 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Region, (2016-2025) ($MN)
Table 2 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Therapy Type, (2016-2025) ($MN)
Table 3 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Blood Transfusion, (2016-2025) ($MN)
Table 4 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Gene Therapy, (2016-2025) ($MN)
Table 5 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Bone Marrow Transplant, (2016-2025) ($MN)
Table 6 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Medications, (2016-2025) ($MN)
Table 7 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Vaccines, (2016-2025) ($MN)
Table 8 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Antibiotics, (2016-2025) ($MN)
Table 9 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Analgesics, (2016-2025) ($MN)
Table 10 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Antimetabolites, (2016-2025) ($MN)
Table 11 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Folic Acid, (2016-2025) ($MN)
Table 12 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Pain-Relieving Medications, (2016-2025) ($MN)
Table 13 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Hydroxyurea, (2016-2025) ($MN)
Table 14 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Other Medications, (2016-2025) ($MN)
Table 15 Global Sickle-Cell Anemia Therapeutics Market Analysis, by End User , (2016-2025) ($MN)
Table 16 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Private Clinics, (2016-2025) ($MN)
Table 17 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Hospitals, (2016-2025) ($MN)
Table 18 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Government, (2016-2025) ($MN)
Table 19 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Infusion Centers, (2016-2025) ($MN)
Table 20 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Home Healthcare, (2016-2025) ($MN)
Table 21 Global Sickle-Cell Anemia Therapeutics Market Analysis, by Other End Users, (2016-2025) ($MN)
Table 22 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Country, (2016-2025) ($MN)
Table 23 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Therapy Type, (2016-2025) ($MN)
Table 24 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Blood Transfusion, (2016-2025) ($MN)
Table 25 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Gene Therapy, (2016-2025) ($MN)
Table 26 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Bone Marrow Transplant, (2016-2025) ($MN)
Table 27 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Medications, (2016-2025) ($MN)
Table 28 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Vaccines, (2016-2025) ($MN)
Table 29 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Antibiotics, (2016-2025) ($MN)
Table 30 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Analgesics, (2016-2025) ($MN)
Table 31 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Antimetabolites, (2016-2025) ($MN)
Table 32 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Folic Acid, (2016-2025) ($MN)
Table 33 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Pain-Relieving Medications, (2016-2025) ($MN)
Table 34 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Hydroxyurea, (2016-2025) ($MN)
Table 35 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Other Medications, (2016-2025) ($MN)
Table 36 North America Sickle-Cell Anemia Therapeutics Market Analysis, by End User , (2016-2025) ($MN)
Table 37 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Private Clinics, (2016-2025) ($MN)
Table 38 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Hospitals, (2016-2025) ($MN)
Table 39 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Government, (2016-2025) ($MN)
Table 40 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Infusion Centers, (2016-2025) ($MN)
Table 41 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Home Healthcare, (2016-2025) ($MN)
Table 42 North America Sickle-Cell Anemia Therapeutics Market Analysis, by Other End Users, (2016-2025) ($MN)
Table 43 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Country, (2016-2025) ($MN)
Table 44 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Therapy Type, (2016-2025) ($MN)
Table 45 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Blood Transfusion, (2016-2025) ($MN)
Table 46 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Gene Therapy, (2016-2025) ($MN)
Table 47 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Bone Marrow Transplant, (2016-2025) ($MN)
Table 48 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Medications, (2016-2025) ($MN)
Table 49 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Vaccines, (2016-2025) ($MN)
Table 50 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Antibiotics, (2016-2025) ($MN)
Table 51 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Analgesics, (2016-2025) ($MN)
Table 52 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Antimetabolites, (2016-2025) ($MN)
Table 53 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Folic Acid, (2016-2025) ($MN)
Table 54 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Pain-Relieving Medications, (2016-2025) ($MN)
Table 55 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Hydroxyurea, (2016-2025) ($MN)
Table 56 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Other Medications, (2016-2025) ($MN)
Table 57 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by End User , (2016-2025) ($MN)
Table 58 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Private Clinics, (2016-2025) ($MN)
Table 59 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Hospitals, (2016-2025) ($MN)
Table 60 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Government, (2016-2025) ($MN)
Table 61 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Infusion Centers, (2016-2025) ($MN)
Table 62 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Home Healthcare, (2016-2025) ($MN)
Table 63 Europe Sickle-Cell Anemia Therapeutics Market Analysis, by Other End Users, (2016-2025) ($MN)
Table 64 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Country, (2016-2025) ($MN)
Table 65 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Therapy Type, (2016-2025) ($MN)
Table 66 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Blood Transfusion, (2016-2025) ($MN)
Table 67 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Gene Therapy, (2016-2025) ($MN)
Table 68 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Bone Marrow Transplant, (2016-2025) ($MN)
Table 69 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Medications, (2016-2025) ($MN)
Table 70 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Vaccines, (2016-2025) ($MN)
Table 71 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Antibiotics, (2016-2025) ($MN)
Table 72 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Analgesics, (2016-2025) ($MN)
Table 73 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Antimetabolites, (2016-2025) ($MN)
Table 74 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Folic Acid, (2016-2025) ($MN)
Table 75 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Pain-Relieving Medications, (2016-2025) ($MN)
Table 76 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Hydroxyurea, (2016-2025) ($MN)
Table 77 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Other Medications, (2016-2025) ($MN)
Table 78 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by End User , (2016-2025) ($MN)
Table 79 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Private Clinics, (2016-2025) ($MN)
Table 80 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Hospitals, (2016-2025) ($MN)
Table 81 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Government, (2016-2025) ($MN)
Table 82 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Infusion Centers, (2016-2025) ($MN)
Table 83 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Home Healthcare, (2016-2025) ($MN)
Table 84 Asia Pacific Sickle-Cell Anemia Therapeutics Market Analysis, by Other End Users, (2016-2025) ($MN)
Table 85 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Country, (2016-2025) ($MN)
Table 86 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Therapy Type, (2016-2025) ($MN)
Table 87 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Blood Transfusion, (2016-2025) ($MN)
Table 88 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Gene Therapy, (2016-2025) ($MN)
Table 89 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Bone Marrow Transplant, (2016-2025) ($MN)
Table 90 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Medications, (2016-2025) ($MN)
Table 91 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Vaccines, (2016-2025) ($MN)
Table 92 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Antibiotics, (2016-2025) ($MN)
Table 93 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Analgesics, (2016-2025) ($MN)
Table 94 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Antimetabolites, (2016-2025) ($MN)
Table 95 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Folic Acid, (2016-2025) ($MN)
Table 96 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Pain-Relieving Medications, (2016-2025) ($MN)
Table 97 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Hydroxyurea, (2016-2025) ($MN)
Table 98 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Other Medications, (2016-2025) ($MN)
Table 99 South America Sickle-Cell Anemia Therapeutics Market Analysis, by End User , (2016-2025) ($MN)
Table 100 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Private Clinics, (2016-2025) ($MN)
Table 101 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Hospitals, (2016-2025) ($MN)
Table 102 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Government, (2016-2025) ($MN)
Table 103 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Infusion Centers, (2016-2025) ($MN)
Table 104 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Home Healthcare, (2016-2025) ($MN)
Table 105 South America Sickle-Cell Anemia Therapeutics Market Analysis, by Other End Users, (2016-2025) ($MN)
Table 106 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Country, (2016-2025) ($MN)
Table 107 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Therapy Type, (2016-2025) ($MN)
Table 108 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Blood Transfusion, (2016-2025) ($MN)
Table 109 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Gene Therapy, (2016-2025) ($MN)
Table 110 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Bone Marrow Transplant, (2016-2025) ($MN)
Table 111 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Medications, (2016-2025) ($MN)
Table 112 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Vaccines, (2016-2025) ($MN)
Table 113 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Antibiotics, (2016-2025) ($MN)
Table 114 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Analgesics, (2016-2025) ($MN)
Table 115 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Antimetabolites, (2016-2025) ($MN)
Table 116 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Folic Acid, (2016-2025) ($MN)
Table 117 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Pain-Relieving Medications, (2016-2025) ($MN)
Table 118 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Hydroxyurea, (2016-2025) ($MN)
Table 119 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Other Medications, (2016-2025) ($MN)
Table 120 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by End User , (2016-2025) ($MN)
Table 121 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Private Clinics, (2016-2025) ($MN)
Table 122 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Hospitals, (2016-2025) ($MN)
Table 123 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Government, (2016-2025) ($MN)
Table 124 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Infusion Centers, (2016-2025) ($MN)
Table 125 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Home Healthcare, (2016-2025) ($MN)
Table 126 Middle East & Africa Sickle-Cell Anemia Therapeutics Market Analysis, by Other End Users, (2016-2025) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook